⌘K

Login Start Free

Home/Filings/4/0000921895-22-000660

4//SEC Filing

Casale Robert 4

Accession 0000921895-22-000660

CIK 0001497504other

View on SEC.gov Company Profile

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 8:12 PM ET

Size

5.6 KB

Accession

0000921895-22-000660

Insider Transaction Report

Form 4

Period: 2022-02-22

PLx Pharma Inc.PLXP

Director

Transactions

Award
Stock Option (right to buy)
2022-02-22+20,000→ 20,000 total
Exercise: $4.99Exp: 2032-02-22→ Common Stock (20,000 underlying)

Footnotes (2)

[F1]Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan, as amended.
[F2]These stock options vest in full on the first anniversary of the grant date.

Documents

1 file

4
form411577cas_02242022.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

PLx Pharma Inc.

CIK 0001497504

Entity typeother

Related Parties

1

filerCIK 0001661196

Filing Metadata

Form type: 4
Filed: Feb 23, 7:00 PM ET
Accepted: Feb 24, 8:12 PM ET
Size: 5.6 KB

View on SEC.gov